Constellation Brands (STZ)
$197.02 0.27 (0.14%)
18:33 EDT STZ Stock Quote Delayed 15 Minutes
Previous Close $197.02
Market Cap 33.07B
PE Ratio 14.77
Volume (Avg. Vol.) 843,400
Day's Range 196.00 - 198.60
52-Week Range 150.37 - 227.35
Dividend & Yield 2.74 (1.39%)
STZ Stock Predictions, Articles, and Constellation Brands News
- From InvestorPlace
- From the Web
PepsiCo delivered healthy organic sales in Q3 2019. That makes it one of seven possible beverage stocks to buy.
CGC stock continued its long slide on Friday, but Canopy Growth stock has many upcoming positive catalysts.
Here's what happened in the stock market today, as equities posted a strong bounce after an early morning flush.
Constellation Brands (STZ) earnings for the alcohol company's fiscal second quarter of 2020 has STZ stock taking a hit on Thursday.
Constellation booted Canopy's old CEO and installed a new business strategy. But there's little sign that it is leading to any improvement in CGC's outlook.
Cannabis stocks are in a bear phase and it is taking CGC stock down with it. Beyond next year, profits are around the corner.
Canopy Growth continues to have issues with its leadership transition. Because of this the price of CGC stock has declined.
Shares of Canopy Growth stock have been struggling immensely over the last few months. However, CGC has some new momentum.
Constellation CEO Bill Newlands insists people will pay more for quality products, whether that's beer, wine, booze or pot.
Like other cannabis investments, Aurora Cannabis stock has suffered incredible volatility recently. In order to generate some confidence, ACB stock must start justifying its rich premium.
The stock charts of FTI, VRTX and STZ are knocking on the doors of major moves, even if the broad market isn't.
Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
Canopy Growth invested ahead of marijuana market growth that has yet to develop, and Constellation Brands invested in CGC.
CGC stock is at a crucial technical juncture as Canopy Growth approaches the release of last quarter's numbers. Other pot stocks are apt to follow its lead.
By Jay Yao
Despite falling from the highs, TLRY has potential. Here are three potential positive catalysts that could unlock Tilray's potential.
Aphria stock hasn't been trading well, like most of its cannabis stock peers. Is the stock undervalued or unhealthy at current levels?
HEXO stock is losing ground like most other pot stocks, but management is most definitely building a differentiated company.
CGC stock is suddenly a liability after the industry's problems started to weigh on CGC stock price in recent weeks
Canopy Growth saw its shares fall 5% last week after CEO Bruce Linton was fired. But Linton's firing is good news for CGC stock going forward.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!